We also found that OCN levels were elevated in patients with non‐AD neurodegenerative diseases, such as frontotemporal dementia (FTD) and multiple system atrophy (MSA), suggesting that OCN changes are not specific to AD. Here, BGLAP is linked to multiple system atrophy.